Previous 10 | Next 10 |
Salt Lake City, UT, Oct. 03, 2019 (GLOBE NEWSWIRE) -- Co-Diagnostics, Inc. (Nasdaq: CODX) , a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today that it will be presenting liquid biopsy applications of its paten...
Salt Lake City, UT, Sept. 19, 2019 (GLOBE NEWSWIRE) -- Co-Diagnostics, Inc. (Nasdaq: CODX) , a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today that it will be hosting a booth and launching its vector control ...
New York City, NY, Sept. 11, 2019 (GLOBE NEWSWIRE) -- Analysts for Co-Diagnostics, Inc. (Nasdaq: CODX) , a molecular diagnostics company with a patented diagnostic testing platform, maintained their Buy rating with a target well above the current price following news last week that increas...
Salt Lake City, Utah, Sept. 04, 2019 (GLOBE NEWSWIRE) -- Co-Diagnostics, Inc. (Nasdaq: CODX) (“Co-Diagnostics,” or the “Company”), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, and LGC, Biose...
New York City, New York, Aug. 29, 2019 (GLOBE NEWSWIRE) -- The Wall Street Analyzer recently completed and published an interview with the CEO of Co-Diagnostics, Inc. (Nasdaq: CODX) , a molecular diagnostics company with a unique, patented platform for the development of molecular diagnost...
Salt Lake City, Utah, Aug. 28, 2019 (GLOBE NEWSWIRE) -- Co-Diagnostics, Inc. (Nasdaq: CODX) , a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today that it will be featured as a presenting company at the 21 st A...
Salt Lake City, Utah, Aug. 21, 2019 (GLOBE NEWSWIRE) -- Co-Diagnostics, Inc. (Nasdaq: CODX) , a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today that it will host the 2 nd Semiannual Co-Diagnostics Distributo...
DPW Holdings (NYSEMKT: DPW ) +287% as its subsidiary, Digital Power Lending, LLC relaunched monthlyinterest.com More news on: DPW Holdings, Inc., Yuma Energy, Inc., China Green Agriculture, Inc., Stocks on the move, Read more ...
Co-Diagnostics (NASDAQ: CODX ): Q2 GAAP EPS of -$0.08 misses by $0.02 . More news on: Co-Diagnostics, Inc., Earnings news and commentary, Healthcare stocks news, , Read more ...
Salt Lake City, UT, Aug. 14, 2019 (GLOBE NEWSWIRE) -- Co-Diagnostics, Inc. (Nasdaq: CODX) , a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today the filing of its operating results on SEC Form 10-Q for the 3 mon...
News, Short Squeeze, Breakout and More Instantly...
Co-Diagnostics, Inc. Reports First Quarter 2024 Financial Results PR Newswire SALT LAKE CITY , May 9, 2024 /PRNewswire/ -- Co-Diagnostics, Inc. (NASDAQ: CODX) ("Co-Dx," or the "Company"), a molecular diagnostics company with a unique, patented platform for the de...
AlloVir Inc. (ALVR) is expected to report $-0.16 for Q1 2024 Inter & Co. Inc. (INTR) is expected to report $0.08 for Q1 2024 Array Technologies Inc. (ARRY) is expected to report $-0.06 for Q1 2024 Sphere 3D Corp. (ANY) is expected to report $-0.23 for Q1 2024 Alpine Immune Sci...
Co-Diagnostics, Inc. Announces First Quarter 2024 Earnings Release Date and Webcast PR Newswire SALT LAKE CITY , April 25, 2024 /PRNewswire/ -- Co-Diagnostics, Inc. (NASDAQ: CODX), a molecular diagnostics company with a unique, patented platform for the developme...